Canale R, Barone R J, Gimenez N S, Santopietro M, Ramirez L, Palliotti A, Romero P, Amado D
Servicio de Terapia Renal Hurlingham SRL, Centro Integral de Diálisis, Hospital Israelita, Buenos Aires, Argentina.
Adv Perit Dial. 2001;17:230-4.
With the aim of evaluating nutrition indices and dialysis adequacy level in patients who started peritoneal dialysis (PD) without residual renal function, we retrospectively studied 19 patients [8 men, 11 women; 3 with diabetes (15.8%); mean age: 44.5 +/- 10.74 years; 15 on continuous ambulatory peritoneal dialysis (CAPD), 3 on continuous cycling peritoneal dialysis (CCPD), 1 on nightly intermittent peritoneal dialysis (NIPD)]. The mean time spent by these patients on hemodialysis before PD was 62.7 +/- 54.7 months (range: 8.8-216 months), and the mean time on PD was 46.2 +/- 21.4 months (range: 10-75 months). In these patients, we measured weekly Kt/V urea, weekly creatinine clearance (CrC), normalized protein catabolic rate (nPCR), body surface area (BSA), urea distribution volume (V), serum albumin, body mass index (BMI), percent lean body mass (%LBM), infusion volume (liters per day), subjective global assessment (SGA), and peritoneal equilibration test (PET). Using the Student t-test at a significance level of p < 0.05, we compared initial body weight (INW), actual weight (AW), and ideal body weight (IBW) according to age, sex, and height. We analyzed actuarial and technique survival (Kaplan-Meier). In regard to patient survival, only death was considered the end point; for technique survival, only technique failure was considered the end point. Data are expressed as mean +/- standard deviation. Results were: Kt/V, 2.20 +/- 0.46 L weekly; CrC, 59.11 +/- 12 L weekly; nPCR, 1.08 +/- 0.25 g/kg daily; BSA, 1.67 +/- 0.2 m2; V, 33.34 +/- 7.12; serum albumin, 3.68 +/- 0.22 g/dL; BMI, 24.06 +/- 4.16; %LBM, 64.92 +/- 10.13; SGA, 94.7% well-nourished; AW, 65.37 +/- 13.88 kg; IBW, 67.21 +/- 10.5 kg (AW vs IBW: r = 0.69, p > 0.05); INW, 61.54 +/- 11.07 kg (INW vs AW: r = 0.92, p < 0.05; INW vs IBW: r = 0.71, p < 0.05). Distribution of transport status by PET was 15.8% high transport, 36.8% high-average transport, 36.8% low-average transport, and 10.5% low transport. Mean infusion volume was 10.41 +/- 1.36 L in 24 hours. Cumulative survival was 100%, 98%, and 82% after 1, 2, and 6 years respectively. Technique survival was 100% after 6 years. The adequacy results accord with Dialysis Outcomes Quality Initiative (DOQI) recommendations, and the nutrition indices and actuarial and technique survival are satisfactory for anuric patients.
为了评估开始腹膜透析(PD)时无残余肾功能患者的营养指标和透析充分性水平,我们回顾性研究了19例患者[8例男性,11例女性;3例患有糖尿病(15.8%);平均年龄:44.5±10.74岁;15例接受持续非卧床腹膜透析(CAPD),3例接受持续循环腹膜透析(CCPD),1例接受夜间间歇性腹膜透析(NIPD)]。这些患者在开始PD前接受血液透析的平均时间为62.7±54.7个月(范围:8.8 - 216个月),接受PD的平均时间为46.2±21.4个月(范围:10 - 75个月)。在这些患者中,我们测量了每周的尿素Kt/V、每周肌酐清除率(CrC)、标准化蛋白分解代谢率(nPCR)、体表面积(BSA)、尿素分布容积(V)、血清白蛋白、体重指数(BMI)、瘦体重百分比(%LBM)、每日输注量(升/天)、主观全面评定(SGA)以及腹膜平衡试验(PET)。使用显著性水平为p < 0.05的Student t检验,我们根据年龄、性别和身高比较了初始体重(INW)、实际体重(AW)和理想体重(IBW)。我们分析了精算生存率和技术生存率(Kaplan - Meier法)。关于患者生存率,仅将死亡视为终点;对于技术生存率,仅将技术失败视为终点。数据以平均值±标准差表示。结果如下:Kt/V为每周2.20±0.46 L;CrC为每周59.11±12 L;nPCR为每日1.08±0.25 g/kg;BSA为1.67±0.2 m²;V为33.34±7.12;血清白蛋白为3.68±0.22 g/dL;BMI为24.06±4.16;%LBM为64.92±10.13;SGA显示94.7%营养良好;AW为65.37±13.88 kg;IBW为67.21±10.5 kg(AW与IBW比较:r = 0.69,p > 0.05);INW为61.54±11.07 kg(INW与AW比较:r = 0.92,p < 0.05;INW与IBW比较:r = 0.71,p < 0.05)。PET的转运状态分布为:高转运15.8%,高 - 平均转运36.8%,低 - 平均转运36.8%,低转运10.5%。24小时内平均输注量为10.41±1.36 L。1年、2年和6年后的累积生存率分别为100%、98%和82%。6年后技术生存率为100%。充分性结果符合透析结果质量倡议(DOQI)的建议,营养指标以及精算生存率和技术生存率对于无尿患者而言令人满意。